An evaluation of current and future trends in the pharmaceutical industry
Unintentional child poisoning remains a global societal issue and a considerable risk in the home.
In the United States (U.S.), every day, two children die because of poisoning.
In the European Union (EU), poisoning is the fifth leading cause of unintentional death for children.
One of the most commonly cited causes of poisoning is accidental ingestion of medicinal drugs.
Despite a downward trend in poisoning cases thanks to better regulations and awareness, the risk of poisoning still exists, and patients and stakeholders are calling on pharmaceutical companies to recognize the importance of child- resistant closures (CRCs) in medical packaging.
Since its introduction, child-resistant packaging has developed to become a must-have in some regions and is rapidly gaining acceptance in others. However, discrepancies between regions still exists and some reluctancy persists.
An important feature of child-resistant packaging is the ability of older patients to access medication, while simultaneously ensuring children cannot open it.
While most packaging solutions must meet child-resistant senior friendly (CRSF) certification protocols, concern remains around the impact of CRCs on elderly patient compliance.
This webinar will cover these trends, and reviews current research and viewpoints of the industry in child-resistant packaging innovation.
Presented by
Najet Mebarki,
Senior Product Marketing Manager
Najet Mebarki is Senior Product Marketing Manager for oral products at SGD Pharma, since 2018.
She has 15 years of experience in BtoB marketing within the packaging sector, in international companies and multicultural environments.
Her role is to translate market insights into business value by developing the most suitable product & service offering.
Most recently, Najet developed Ensiemo, a CRC packaging solution dedicated to the CBD oil market.
Dr Rolf Abelmann,
Managing Director, IVM Childsafe GmbH
Born 1976 and schooled in the city of Braunschweig, Germany. Completed his higher level school qualifications in 1995. Shortly after this he completed his conscription from 1995 to 1996. In 1996 till 2000 he studied business at the University of Göttingen. Secured a management position with ALDI from 2001 to 2003. He joined ivm-childsafe (ivm Institut VerpackungsMarktforschung) in 2003 as head of testing. Meanwhile he also completed his doctorate with the University of Göttingen in 2005. In 2006 he became the Managing Director of IVM.
Andrew Smith,
Technical packaging director, GlaxoSmithKline
Andrew has been with GSK for 27 years and has held varying roles across the business including R&D Packaging Development, Anti-counterfeit specialist and Child Resistant Senior Friendly (CRSF) solutions lead. In his current role of Manufacturing Science & Technology (MSAT) Packaging Director he’s accountable for defining the primary pack standards, including CRSF for GSK’s prescription medicine portfolio.
